Finance

Lists
AJANTPHARM:NSE
Ajanta Pharma Ltd
၃,၃၄၈.၅၀ ₹
-၀.၃၂%
(-၁၀.၉၀) 1D
အောက် ၁၆, GMT+၅:၃၀ ၁၃:၁၁:၀၉  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AJANTPHARM...
Open
၃,၃၇၂.၅၀ ₹
High
၃,၃၈၁.၀၀ ₹
Low
၃,၃၂၂.၆၀ ₹
Mkt. cap
ဋေ ၄.၁၉ သ
Avg. vol.
၉.၀၂ သောင်း
Volume
၂.၀၈ သောင်း
Dividend
၁.၅၈%
Quarterly dividend
၁၃.၂၅ ₹
Ex-dividend date
၂၀၂၆ ဩ ၅
P/E ratio
၃၆.၈၆
52-wk high
၃,၇၉၆.၀၀ ₹
52-wk low
၂,၃၈၂.၀၀ ₹
EPS
၉၀.၈၃ ₹
Shares outstanding
၈.၈၄ ကုဋေ
No. of employees
၁ သောင်း
Open
၃,၃၇၂.၅၀ ₹
High
၃,၃၈၁.၀၀ ₹
Low
၃,၃၂၂.၆၀ ₹
Mkt. cap
ဋေ ၄.၁၉ သ
Avg. vol.
၉.၀၂ သောင်း
Volume
၂.၀၈ သောင်း
Dividend
၁.၅၈%
Quarterly dividend
၁၃.၂၅ ₹
Ex-dividend date
၂၀၂၆ ဩ ၅
P/E ratio
၃၆.၈၆
52-wk high
၃,၇၉၆.၀၀ ₹
52-wk low
၂,၃၈၂.၀၀ ₹
EPS
၉၀.၈၃ ₹
Shares outstanding
၈.၈၄ ကုဋေ
No. of employees
၁ သောင်း
News stories
From web sources and news partners
TradingView
TradingView
·
ပြီးခဲ့သည့် ၄၁ မိနစ်
Key facts: NASDAQ:ASTS delayed 2027; Piper Sandler Neutral; $1B note
Bloomberg
Bloomberg
·
ပြီးခဲ့သည့် ၂၂ မိနစ်
European Shares Outperform S&P 500 Amid Defensive Tilt From AI
Investor's Business Daily
Investor's Business Daily
·
ပြီးခဲ့သည့် ၄ နာရီ
Futures Mixed; Anthropic Value, Tesla Roadster In Focus
Profile
Ajanta Pharma Limited is an Indian multinational pharmaceutical company. The company operates in India, the United States, and over 30 countries across Africa, Southeast Asia, West Asia, and the CIS. It was established in 1973.. Wikipedia
About Ajanta Pharma Ltd
CEO-
Employees၁.၀၄ သောင်း
Founded၁၉၇၃
Headquarters-
Sector-
Last report
၂၀၂၆ ဇူ ၃၀
Fiscal period
Q1 2027
၂၆.၇၂ ₹ / ၂၂.၉၀ ₹
+၁၆.၆၈%beat
Revenue / Est. (INR)
ဋေ ၁.၆၃ ထ / ဋေ ၁.၅၃ ထ
+၆.၂၆%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၃၅ ထ
ဋေ ၁.၃၇ ထ
ဋေ ၁.၄၂ ထ
ဋေ ၁.၆၃ ထ
Cost of goods sold
၃၁၆.၈၁ ဋေ
၂၈၆.၂၆ ဋေ
၃၈၄.၉၉ ဋေ
၃၂၇.၈၅ ဋေ
Cost of revenue
၃၁၆.၈၁ ဋေ
၂၈၆.၂၆ ဋေ
၃၈၄.၉၉ ဋေ
၃၂၇.၈၅ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃၁၇.၀၁ ဋေ
၃၃၀.၅၂ ဋေ
၃၅၀.၂၂ ဋေ
၃၈၁.၁၁ ဋေ
Operating expense
၇၁၁.၁၁ ဋေ
၇၄၉.၈၅ ဋေ
၇၀၅.၀၄ ဋေ
၈၈၈.၄၄ ဋေ
Total operating expenses
ဋေ ၁.၀၃ ထ
ဋေ ၁.၀၄ ထ
ဋေ ၁.၀၉ ထ
ဋေ ၁.၂၂ ထ
Operating income
၃၂၅.၈၁ ဋေ
၃၃၈.၇၃ ဋေ
၃၃၁.၆၁ ဋေ
၄၀၉.၆၇ ဋေ
Other non operating income
၁၉.၇၁ ကုဋေ
၁၆.၄၂ ကုဋေ
-၄၄.၇၉ ကုဋေ
၂၀.၄၃ ကုဋေ
EBT including unusual items
၃၄၀.၈၁ ဋေ
၃၅၈.၆၀ ဋေ
၃၄၇.၁၁ ဋေ
၄၄၆.၈၀ ဋေ
EBT excluding unusual items
၃၄၀.၈၁ ဋေ
၃၅၈.၆၀ ဋေ
၄၄၁.၇၇ ဋေ
၄၄၆.၈၀ ဋေ
Income tax expense
၈၀.၆၂ ကုဋေ
၈၄.၈၃ ကုဋေ
၈၀.၄၁ ကုဋေ
၁၁၂.၅၈ ဋေ
Effective tax rate
၂၃.၆၆%
၂၃.၆၆%
၂၃.၁၇%
၂၅.၂၀%
Other operating expenses
၃၅၁.၁၃ ဋေ
၃၇၅.၈၂ ဋေ
၃၀၉.၄၅ ဋေ
၄၆၂.၈၃ ဋေ
Net income
၂၆၀.၁၉ ဋေ
၂၇၃.၇၇ ဋေ
၂၆၆.၇၀ ဋေ
၃၃၄.၂၂ ဋေ
Net profit margin
၁၉.၂၂%
၁၉.၉၁%
၁၈.၇၆%
၂၀.၅၆%
Earnings per share
၂၀.၈၂
၂၁.၉၁
၂၁.၃၄
၂၆.၇၂
Interest and investment income
-
-
၅၁.၆၀ ကုဋေ
-
Interest expense
-၃.၃၉ ကုဋေ
-၅.၁၀ ကုဋေ
-၂.၃၆ ကုဋေ
-၃.၁၈ ကုဋေ
Net interest expenses
-၃.၃၉ ကုဋေ
-၅.၁၀ ကုဋေ
၄၉.၂၄ ကုဋေ
-၃.၁၈ ကုဋေ
Depreciation and amortization charges
၄၂.၉၇ ကုဋေ
၄၃.၅၁ ကုဋေ
၄၅.၃၇ ကုဋေ
၄၄.၅၀ ကုဋေ
EBITDA
၃၆၇.၉၄ ဋေ
၃၆၉.၆၈ ဋေ
၃၇၀.၄၆ ဋေ
၄၄၈.၅၂ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ